(Press-News.org) Contact information: Andrea Slesinski
aslesinski@hematology.org
202-552-4927
American Society of Hematology
American Society of Hematology releases list of commonly used tests and treatments to question as part of Choosing Wisely campaign
Group aims to encourage physician and patient conversations by identifying 5 tests or procedures to question, highlighting potentially unnecessary -- sometimes harmful -- practices in hematology
(WASHINGTON, December 4, 2013) – The The American Society of Hematology (ASH), the world's largest professional organization dedicated to the causes and treatments of blood disorders, today released a list of common hematology tests, treatments, and procedures that are not always necessary as part of Choosing Wisely®, an initiative of the ABIM Foundation. The list, also highlighted in a manuscript published online today in Blood, the Journal of the American Society of Hematology, makes five evidence-based recommendations in an effort to prompt conversations between patients and physicians about the necessity and potential harm of certain practices. ASH's Choosing Wisely list (available at http://www.hematology.org/choosingwisely identifies the following five tests, treatments, and procedures that hematologists and their patients should question:
Limit surveillance computed tomography (CT) scans in asymptomatic patients following curative-intent treatment for aggressive lymphoma.
Don't use inferior vena cava (IVC) filters routinely in patients with acute venous thromboembolism (VTE).
Do not transfuse more than the minimum number of red blood cell (RBC) units necessary to relieve symptoms of anemia or to return a patient to a safe hemoglobin range (7 to 8 g/dL in stable, non-cardiac, in-patients).
Don't test for thrombophilia in adult patients with venous thromboembolism (VTE) occurring in the setting of major transient risk factors (surgery, trauma or prolonged immobility).
Don't administer plasma or prothrombin complex concentrates for non-emergent reversal of vitamin K antagonists (i.e. outside of the setting of major bleeding, intracranial hemorrhage or anticipated emergent surgery).
The ASH Choosing Wisely list was developed after months of careful data analysis and review as well as input from the ASH membership, using the most current evidence about management and treatment options, with the goal of starting a conversation both within the hematology community and among physicians and their patients about quality of care.
"Hematology is a specialty with many new and increasingly expensive tests and treatments. While these new diagnostic and treatment strategies represent important advances, there is also potential to pose significant harm and cost to patients if over- or misused," said Lisa Hicks, MD, of St. Michael's Hospital and the University of Toronto and chair of the ASH Choosing Wisely Task Force. "The ASH Choosing Wisely list serves as a reminder to hematologists to take a step back and question whether certain routinely used procedures are really necessary, and to gradually change their practices to maximize the value of care."
One element unique to ASH's list is the concept of avoiding harm as the dominant guiding principle for the rigorous selection process for list items. The four other established guiding principles of the Choosing Wisely campaign are evidence, cost, frequency, and scope of practice. Therefore, those tests, procedures, or treatments deemed as increasing risk of harm were prioritized for inclusion on ASH's Choosing Wisely list.
"ASH has shown tremendous leadership by releasing its list of tests and procedures that are commonly performed in hematology but aren't always necessary," said Richard J. Baron, MD, president and CEO of the ABIM Foundation. "The content of this list and all of the others developed through this effort are helping physicians and patients across the country engage in conversations about what care they need, and what we can do to reduce waste and overuse in our health-care system."
Since the launch of the Choosing Wisely campaign in April 2012, 92 national and state medical specialty societies, regional health collaborative organizations, and consumer partners have joined this important conversation about appropriate care. ASH's list is part of a third group of Choosing Wisely lists that have been or will be released by more than 30 specialty societies between August 2013 and early 2014. Taken as a whole, these lists identify more than 250 tests and procedures that physicians and patients should discuss before ordering.
The campaign continues to reach millions of consumers nationwide through a stable of consumer and advocacy partners, led by Consumer Reports—the world's largest independent product-testing organization—which has worked with the ABIM Foundation to distribute patient-friendly resources for consumers and physicians to engage in these important conversations.
###
To learn more about Choosing Wisely and to view the complete lists and additional detail about the recommendations and evidence supporting them, visit http://www.ChoosingWisely.org
About ASH:
The American Society of Hematology (ASH) is the world's largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. The official journal of ASH is Blood, the most cited peer-reviewed publication in the field, which is available weekly in print and online.
About the ABIM Foundation
The mission of the ABIM Foundation is to advance medical professionalism to improve the health care system. We achieve this by collaborating with physicians and physician leaders, medical trainees, health care delivery systems, payers, policy makers, consumer organizations and patients to foster a shared understanding of professionalism and how they can adopt the tenets of professionalism in practice. To learn more about the ABIM Foundation, visit http://www.abimfoundation.org, read the ABIM blog blog.abimfoundation.org, or connect with ABIM on Facebook and Twitter.
About Choosing Wisely®
First announced in December 2011, Choosing Wisely® is part of a multi-year effort led by the ABIM Foundation to support and engage physicians in being better stewards of finite health care resources. Participating specialty societies are working with the ABIM Foundation and Consumer Reports to share the lists widely with their members and convene discussions about the physician's role in helping patients make wise choices. Learn more at http://www.ChoosingWisely.org.
American Society of Hematology releases list of commonly used tests and treatments to question as part of Choosing Wisely campaign
Group aims to encourage physician and patient conversations by identifying 5 tests or procedures to question, highlighting potentially unnecessary -- sometimes harmful -- practices in hematology
2013-12-04
ELSE PRESS RELEASES FROM THIS DATE:
Investigating the link between Parkinson's and pesticides
2013-12-04
Investigating the link between Parkinson's and pesticides
In a seemingly simple experiment, a scientist exposes rats to a certain pesticide over several days, and the rodents start showing symptoms remarkably similar to those seen in Parkinson's patients. ...
Carnegie Mellon scheme uses shared visual cues to help people remember multiple passwords
2013-12-04
Carnegie Mellon scheme uses shared visual cues to help people remember multiple passwords
New approach strikes balance between password security and usability
PITTSBURGH—It turns out that the way to keep track of your many passwords to online accounts is the same ...
Can iPads help students learn science? Yes.
2013-12-04
Can iPads help students learn science? Yes.
The scale of the universe can be difficult to comprehend. Pretend you are going to make a scale model with a basketball representing the Earth and a tennis ball as the Moon. How far would you ...
Multiple mates worth the risk for female prairie dogs
2013-12-04
Multiple mates worth the risk for female prairie dogs
FROSTBURG, MD (December 4, 2013) –Mating with more than one male increases reproductive success for female prairie dogs, despite an increase in risks. This is according to ...
Mysteries of Earth's radiation belts uncovered by NASA twin spacecraft
2013-12-04
Mysteries of Earth's radiation belts uncovered by NASA twin spacecraft
DURHAM, N.H. -- Just over a year since launch, NASA's Van Allen Probes mission continues to unravel longstanding mysteries of Earth's high-energy radiation belts that encircle our planet and ...
Data on people's self-reported 'experienced' well-being could help inform policies
2013-12-04
Data on people's self-reported 'experienced' well-being could help inform policies
WASHINGTON -- Gathering survey data on "experienced" well-being – the self-reported levels of contentment, joy, stress, frustration, and other feelings people experience throughout ...
CU-Boulder-led team finds first evidence of primates regularly sleeping in caves
2013-12-04
CU-Boulder-led team finds first evidence of primates regularly sleeping in caves
Scientists have discovered that some ring-tailed lemurs in Madagascar regularly retire to limestone chambers for their nightly snoozes, the first evidence of the consistent, ...
Study finds that carbon monoxide can help shrink tumors and amplify effectiveness of chemotherapy
2013-12-04
Study finds that carbon monoxide can help shrink tumors and amplify effectiveness of chemotherapy
Therapeutic benefits appear linked to cell's energy status; used in combination with chemo, CO helps spare healthy tissue
BOSTON -- In recent years, ...
The first decade: Team reports on US trials of bioenergy grasses
2013-12-04
The first decade: Team reports on US trials of bioenergy grasses
CHAMPAIGN, Ill. — The first long-term U.S. field trials of Miscanthus x giganteus, a towering perennial grass used in bioenergy production, reveal ...
AGU journal highlights -- Dec. 4, 2013
2013-12-04
AGU journal highlights -- Dec. 4, 2013
The following highlights summarize research papers that have been recently published in Geochemistry, Geophysics, Geosystems (G3), Geophysical Research Letters (GRL), and Journal of Geophysical Research-Atmospheres (JGR-D).
In ...
LAST 30 PRESS RELEASES:
New study and major data updates expand the Kids First data ecosystem
Seaweed snare: Sargassum stops sea turtle hatchlings in their tracks
Scientists uncover key to decoupling economic growth from pollution in developing countries
Frailty fuels gut imbalance and post-surgery gastrointestinal risks
BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors
Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC
Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds
Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy
NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC
EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC
Training to improve memory
Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?
Black youth, especially Black girls, use mental health services less than their White peers
Canada must protect youth from sports betting advertising
First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer
Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial
Higher blood pressure in childhood linked to earlier death from heart disease in adulthood
AI helped older adults report accurate blood pressure readings at home
High blood pressure in childhood and premature cardiovascular disease mortality
Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations
Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
[Press-News.org] American Society of Hematology releases list of commonly used tests and treatments to question as part of Choosing Wisely campaignGroup aims to encourage physician and patient conversations by identifying 5 tests or procedures to question, highlighting potentially unnecessary -- sometimes harmful -- practices in hematology